Close Icon
Jan 17, 2018 Webinar

Three Ways ICH E6(R2) Impacts Study Oversight

How can stronger relationships be built between sponsors and CROs? How can sharing trial data improve trial outcomes? What are the best ways to measure performance and conduct between sponsor and CRO?

In light of ICH E6(R2) guidelines, sponsors and CROs are reviewing how well they work together. This webinar presents a detailed look at the performance of sponsor/CRO-driven studies.

Karen McCarthy Schau of Paragon—a leading consulting firm that helps health and life sciences companies become high-performing, compliant, and digitally connected—focuses the discussion on three key strategies:

  • Assessing alignment with guidelines
  • Benefits of risk-based oversight
  • Automation advantages
Watch this Webinar Now!
  • Watch this Webinar Now

  • You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.